Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

738 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical analysis of multiple primary malignancies in the elderly.
Luciani A, Ascione G, Marussi D, Oldani S, Caldiera S, Bozzoni S, Codecà C, Zonato S, Ferrari D, Foa P. Luciani A, et al. Among authors: ferrari d. Med Oncol. 2009;26(1):27-31. doi: 10.1007/s12032-008-9075-x. Epub 2008 May 16. Med Oncol. 2009. PMID: 18483884
[Passive smoking].
Crosignani P, Oldani S, Ferrari D. Crosignani P, et al. Among authors: ferrari d. Epidemiol Prev. 1999 Jan-Mar;23(1):1-3. Epidemiol Prev. 1999. PMID: 10356858 Italian. No abstract available.
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study.
Santoro A, Gebbia V, Pressiani T, Testa A, Personeni N, Arrivas Bajardi E, Foa P, Buonadonna A, Bencardino K, Barone C, Ferrari D, Zaniboni A, Tronconi MC, Cartenì G, Milella M, Comandone A, Ferrari S, Rimassa L. Santoro A, et al. Among authors: ferrari s, ferrari d. Ann Oncol. 2015 Mar;26(3):542-7. doi: 10.1093/annonc/mdu576. Epub 2014 Dec 23. Ann Oncol. 2015. PMID: 25538178 Free article. Clinical Trial.
Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trial.
Ghi MG, Paccagnella A, Ferrari D, Foa P, Alterio D, Codecà C, Nolè F, Verri E, Orecchia R, Morelli F, Parisi S, Mastromauro C, Mione CA, Rossetto C, Polsinelli M, Koussis H, Loreggian L, Bonetti A, Campostrini F, Azzarello G, D'Ambrosio C, Bertoni F, Casanova C, Emiliani E, Guaraldi M, Bunkheila F, Bidoli P, Niespolo RM, Gava A, Massa E, Frattegiani A, Valduga F, Pieri G, Cipani T, Da Corte D, Chiappa F, Rulli E; GSTTC (Gruppo di Studio Tumori della Testa e del Collo) Italian Study Group. Ghi MG, et al. Among authors: ferrari d, d ambrosio c. Ann Oncol. 2017 Sep 1;28(9):2206-2212. doi: 10.1093/annonc/mdx299. Ann Oncol. 2017. PMID: 28911070 Free article. Clinical Trial.
Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patients.
Alongi F, Bignardi M, Garassino I, Pentimalli S, Cavina R, Mancosu P, Reggiori G, Poletti A, Ferrari D, Foa P, Bigoni A, Dragonetti A, Salvatori P, Spahiu O, Fogliata A, Cozzi L, Santoro A, Scorsetti M. Alongi F, et al. Among authors: ferrari d. Strahlenther Onkol. 2012 Jan;188(1):49-55. doi: 10.1007/s00066-011-0006-y. Epub 2011 Dec 24. Strahlenther Onkol. 2012. PMID: 22194030 Clinical Trial.
738 results